Latest News

• share
• favorite_border

MD Anderson recommends ways to get a more affordable colonoscopy.

• share
• favorite_border

Like a bounty hunter returning escapees to custody, a cancer-fighting gene converts organ cells that change into highly mobile stem cells back to their original, stationary state, researchers report online at Nature Cell Biology.

• share
• favorite_border

While studying one tumor-suppressing protein, Cheryl Walker's research team at The University of Texas MD Anderson Cancer Center came across a separate surprise. They found another protective protein known to work inside the cell nucleus moonlighting out in the cell's cytoplasm.

• share
• favorite_border

The American Society for Blood and Marrow Transplantation has honored leader, innovator and educator Richard Champlin, M.D., with its Lifetime Achievement Award during the group's annual meeting Feb. 17-21.

• share
• favorite_border

An essential protein for normal stem cell renewal also promotes the growth of breast cancer stem cells when it's overproduced in those cells, researchers at The University of Texas MD Anderson Cancer Center reported in Cancer Cell.

• share
• favorite_border

MD Anderson encourages everyone to get 30 minutes of daily exercise.

• share
• favorite_border

In an international Phase III randomized study, everolimus, an inhibitor of the mammalian target of rapamycin (mTOR), has shown to dramatically improve progression-free survival for patients with advanced pancreatic neuroendocrine tumors (pNET), according to researchers from The University of Texas MD Anderson Cancer Center.

• share
• favorite_border

A $4 million, five-year grant from the National Cancer Institute will create a Texas regional Community Networks Program Center (CNPC), called Latinos Contra El Cancer, to reduce cancer-related health disparities among Texas Latinos.

• share
• favorite_border

A targeted delivery combination selectively crosses the tight barrier that protects the brain from the bloodstream to home in on and bind to brain tumors, a research team led by scientists from The University of Texas MD Anderson Cancer Center reported in the January issue of the Journal of Clinical Investigation.

• share
• favorite_border

The University of Texas MD Anderson Cancer Center's popular web-based teen prevention and smoking-cessation program, ASPIRE (A Smoking Prevention Interactive Experience), now speaks Spanish.

• share
• favorite_border

Practicing stress management techniques before prostate cancer surgery may help activate the body's immune response leading to quicker recovery, as well as aid in lowering mood disturbance, according to a new study by researchers at The University of Texas MD Anderson Cancer Center.

• share
• favorite_border

The Khalifa bin Zayed Al Nahyan Charity Foundation is granting $150 million to The University of Texas MD Anderson Cancer Center to support genetic-analysis based research, diagnosis and treatment of cancer.

• share
• favorite_border

MD Anderson experts share age-specific cancer prevention tips for women.

• share
• favorite_border

Researchers demonstrate that miR-34a targets the CD44 surface protein, which is common on cancer stem cells, to inhibit formation of cells thought to drive the disease. CD44 is associated with tumor development, progression and metastasis.

• share
• favorite_border

Innovative insights into a vital tumor-suppressing mechanism that is often broken in malignant cells and a type of receptor protein that frequently goes haywire to stimulate cancer growth have earned two scientists at The University of Texas MD Anderson Cancer Center membership in a distinguished association of scholars.

• share
• favorite_border

The interplay between a major tumor-suppressing gene, a truncated chromosome and two sets of microRNAs provides a molecular basis for explaining the less aggressive form of chronic lymphocytic leukemia, an international team of researchers reports today in the Jan. 4 edition of the Journal of the American Medical Association.

• share
• favorite_border

By sticking a chemical group to it at a specific site, a protein arrests an enzyme that may worsen and spread cancer, an international research team led by scientists at The University of Texas MD Anderson Cancer Center reports in the January issue of Nature Cell Biology.

• share
• favorite_border

A study of 781 clinical trial participants about factors associated with DNA methylation in healthy colorectal tissue ties red blood cell folate count to gene silencing.

• share
• favorite_border

The recently identified TRIM24 protein plays an active role in pushing normal breast cells into rapid cell proliferation and, potentially, into breast cancer.

• share
• favorite_border

MD Anderson encourages holiday partygoers to practice mindful behavior.

• share
• favorite_border

Metastatic breast cancer patients whose blood contains circulating tumor cells (CTCs) before or after treatment with high-dose chemotherapy and blood stem cell transplant have shorter survival periods, according to a new study by researchers at The University of Texas MD Anderson Cancer Center in Houston.

• share
• favorite_border

A two-drug combination is safe and active in newly diagnosed acute myeloid leukemia and myelodysplastic syndrome patients who are usually excluded from clinical trials because they have other illnesses or poor performance status - a measure of disease progression - researchers reported this week at the 52nd American Society of Hematology Annual Meeting.

• share
• favorite_border

Behavioral scientist and tobacco-cessation expert, Alexander V. Prokhorov, M.D., Ph.D., at The University of Texas MD Anderson Cancer Center is the recipient of the 2011 American Society of Preventive Oncology (ASPO) Joseph W. Cullen Memorial Award for Excellence in Tobacco Research.

• share
• favorite_border

A pioneering clinical trial is testing the effectiveness in leukemia of a small molecule that shuts down MDM2, a protein that can disable the well-known tumor suppressor p53.

• share
• favorite_border

A new drug appears to help chronic myeloid leukemia patients who are out of treatment options after first- and second-line drugs have failed them or because their cancer cells have a mutation that makes them resistant from the start, researchers reported at the 52nd Annual Meeting of the American Society of Hematology.

• share
• favorite_border

A Conversation With a Living Legend® in Dallas, benefiting The University of Texas MD Anderson Cancer Center, showcases CBS chief Washington correspondent Bob Schieffer as its 21st annual honoree in an interview with NBC News special correspondent Tom Brokaw, 11:30 a.m. to 1:30 p.m. Dec. 13 in the Chantilly Ballroom of the Hilton Anatole, 2201 Stemmons Freeway.

• share
• favorite_border

Red-blood-cell-boosting drugs used to treat anemia may undermine breast cancer treatment with Herceptin, a targeted therapy that blocks the cancer-promoting HER2 protein, researchers from The University of Texas MD Anderson Cancer Center report in the Nov. 16 edition of Cancer Cell.

• share
• favorite_border

MD Anderson’s exercise tips for the holidays.

• share
• favorite_border

A $16-million, five-year grant by the National Cancer Institute's nanomedicine initiative blends the expertise of five research institutions to focus an array of innovative nanotechnologies on improving the outcome of patients with ovarian or pancreatic cancers.

• share
• favorite_border

Phase I trial establishes dose, catalogues side effects, hints at targeted drug’s potential -- 38 percent have objective response, 25 percent have complete remission.

• share
• favorite_border

Researchers have identified an important signaling pathway that, when blocked, significantly decreases the spread of pediatric bone cancer.

• share
• favorite_border

Former President of Mexico Vicente Fox and retired CNN News Group chairman Tom Johnson take the stage Oct. 29 at the Grand Hyatt San Antonio for A Conversation With a Living Legend®. The inaugural luncheon fundraiser in San Antonio, featuring an exclusive onstage interview of Fox by Johnson, benefits the Blanton-Davis Ovarian Cancer Research Program at The University of Texas MD Anderson Cancer Center.

• share
• favorite_border

Mothers who have children diagnosed with cancer now have a better approach to address and cope with stresses associated with their child's disease.

• share
• favorite_border

Long overshadowed by p53, its famous tumor-suppressing sibling, the p63 gene does the tougher, important job of stifling the spread of cancer to other organs, researchers at The University of Texas MD Anderson Cancer Center report in the Oct. 21 issue of Nature.

• share
• favorite_border

MD Anderson anticipates new law’s prevention benefits.

• share
• favorite_border

Golf great Jack Nicklaus and veteran CBS sportscaster Jim Nantz take the stage Oct. 19 at the Hilton Americas-Houston for the 2010 Houston A Conversation With a Living Legend® benefiting The University of Texas MD Anderson Cancer Center. The fourth annual luncheon, featuring an exclusive onstage interview, benefits the MD Anderson Children's Cancer Hospital and already has raised more than $472,000.

• share
• favorite_border

In an international Phase III randomized study, an inhibitor of the mammalian target of rapamycin (mTOR), has shown to dramatically improve progression-free survival for patients with advanced pancreatic neuroendocrine tumors (pNET).

• share
• favorite_border

Louise A. Villejo, executive director of the Patient Education Office at The University of Texas MD Anderson Cancer Center, is the recipient of the 2010 Julie and Ben Rogers Award for Excellence in Education.

• share
• favorite_border

Digging more data out of lung CT scans to improve treatment of lung cancer and diagnosis of chronic obstructive pulmonary disease has earned a physician-scientist at The University of Texas MD Anderson Cancer Center a New Innovator Award from the National Institutes of Health.

• share
• favorite_border

Advances in screening for disease detection, better surgical techniques available to more women, and an increased number of therapies that reduce the risk of relapse in patients with both locally advanced and early stage disease, have collectively contributed to dramatic improvements in breast cancer's survival rates, according to a review of 60 years of patient records at The University of Texas MD Anderson Cancer Center.

• share
• favorite_border

Patients with triple negative breast cancer that also have mutations in the BRCA gene appear to have a lower risk of recurrence, compared to those with the same disease without the deleterious genetic mutation, according to researchers at The University of Texas MD Anderson Cancer Center.

• share
• favorite_border

Long associated with a worse outcome, researchers at The University of Texas MD Anderson Cancer Center have discovered that women treated for breast cancer while pregnant, in fact, have improved disease-free survival and a trend for improved overall survival compared to non-pregnant women treated for the disease.

• share
• favorite_border

Doctoral programs in The University of Texas Graduate School of Biomedical Sciences (GSBS) at Houston - a joint program between The University of Texas Health Science Center at Houston (UTHealth) and The University of Texas MD Anderson Cancer Center - ranked among the best in the nation in the National Research Council assessment released Tuesday.

• share
• favorite_border

The University of Texas MD Anderson Cancer Center is reaching out to southeast Texas via an interactive, arcade-style video game aimed at reducing tobacco use among at-risk teens and adolescents. Alexander V. Prokhorov, M.D., Ph.D., professor in the Department of Behavioral Science and director of the Tobacco Outreach Education Program, will unveil a kiosk featuring HealthScare General Hospital at a 10 a.m. ceremony Sept. 28 hosted by the Jefferson County Juvenile Probation Department at the Minnie Rogers Juvenile Justice Center in Beaumont. The event marks MD Anderson's first community installation of the multimedia educational tool.

• share
• favorite_border

An oral medication produces significant and lasting relief for patients with myelofibrosis, a debilitating and lethal bone marrow disorder, researchers at The University of Texas MD Anderson Cancer Center report in the Sept. 16 New England Journal of Medicine.

• share
• favorite_border

Experts at MD Anderson Cancer Center say PSA test is still an effective way to track trends in a man's prostate over time. Doing this increases the chances that prostate cancer will be found as early as possible.

• share
• favorite_border

Specific prevention and education strategies are needed to address breast cancer in Mexican-origin women in this country, according to a study at The University of Texas MD Anderson Cancer Center, which was published online in the journal Cancer.

• share
• favorite_border

UT MD Anderson Cancer Center experts discourage supplement use for cancer prevention.

• share
• favorite_border

Dallas businessman and philanthropist H. Ross Perot has donated $20 million to The University of Texas MD Anderson Cancer Center for research to advance and design novel targeted therapies.

• share
• favorite_border

For the first time, Salt Inducible Kinase 2 (SIK2) has been found to play a critical role in cell division and to regulate the response of some ovarian cancers to chemotherapy.